BOTH VEDOLIZUMAB AND ANTI-TNF THERAPY ARE ASSOCIATED WITH ATTENUATION OF SEROLOGICAL AND NEUTRALIZING RESPONSES TO SARS-COV-2 INFECTION IN INFLAMMATORY BOWEL DISEASE

Wellens, Judith, Edmans, Matthew, Obolski, Uri, Marlow, Luke, Brann, Stephanie, Dunachie, Susanna, Eyre, David W.; Helmus, Drew, Barnes, Eleanor, Colombel, Jean Frederic, Wong, Serre-Yu, Klenerman, Paul, Lindsay, James O.; Thompson, Craig, Satsangi, Jack J.

Wellens, Judith, Edmans, Matthew, Obolski, Uri, Marlow, Luke, Brann, Stephanie, Dunachie, Susanna, Eyre, David W.; Helmus, Drew, Barnes, Eleanor, Colombel, Jean Frederic, Wong, Serre-Yu, Klenerman, Paul, Lindsay, James O.; Thompson, Craig, Satsangi, Jack J..

Gastroenterology ; 162(7):S-278-S-278, 2022.

Article in English | EuropePMC | ID: covidwho-1905443

Search on Google

XML

Collection: Databases of international organizations Database: EuropePMC Language: English Journal: Gastroenterology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

Collection: Databases of international organizations Database: EuropePMC Language: English Journal: Gastroenterology Year: 2022 Document Type: Article